GTCR to acquire Surmodics for $627 million

Surmodics entered into a definitive agreement to be acquired by private equity firm GTCR for $43.00 per share in cash, representing an equity value of approximately $627 million.

“Surmodics, Inc. today announced that it has entered into a definitive agreement to be acquired by GTCR.”surmodics.gcs-web.com

• 1 source
• surmodics.gcs-web.comSurmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million | Surmodics, Inc.May 29, 2024

Summarized from public sources; check the original articles before acting on it.